Effects of Cadmium, Lead, Manganese, and Zinc at WHO Safe Limits in Drinking Water on the in Vitro Availability of Chloramphenicol by Musa, A & Nasir, I
Available online at http://www.ajol.info/index.php/njbas/index  




Effects of Cadmium, Lead, Manganese, and Zinc at WHO Safe Limits in Drinking Water on the in 
Vitro Availability of Chloramphenicol 
 
1A. Musa and *2I. Nasir. 
1Department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmaceutical Sciences,  
Ahmadu Bello University, Zaria, Nigeria. 
2Department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmaceutical Sciences,  
Usmanu Danfodiyo University, Sokoto, Nigeria. 




















ABSTRACT: In the present study, The in vitro availability of chloramphenicol was studied in the presence of lead 
(Pb), cadmium (Cd), manganese (Mn) and zinc (Zn) at 0.01, 0.003, 0.5 and 3 mg/L respectively corresponding to 
WHO safe limits in drinking water for each of the metals. The in vitro availability study was carried out in simulated 
gastric juice (0.1 M HCl) and intestinal pH (phosphate buffer pH 9.0) at 37°C using a dissolution apparatus. 
Samples were taken at 15 minutes intervals over a period of 3 hours and analyzed for concentration of 
chloramphenicol available using a Helios Zeta Model 164617 UV/VIS spectrophotometer at 278nm. In simulated 
gastric juice, a maximum availability of 99.48 % was achieved for chloramphenicol alone, while 89.48, 93.48, 
105.88 and 93.60% of the drug was detected in the presence of Cd, Mn, Pb, and Zn respectively. The 
corresponding maximum availabilities in simulated intestinal pH were 64.12 for chloramphenicol alone, and 64.36, 
83.76, 80.72 and 64.96 % in the presence of Cd, Mn, Pb, and Zn respectively. The presence of Cd did not affect 
the overall availability of chloramphenicol in both media; while the availability of the drug was observed to increase 
slightly in the presence of Pb in both media. In simulated gastric juice, Mn and Zn did not affect the availability of 
chloramphenicol. However, their presence slightly increased the availability of the drug in simulated intestinal pH. 
The results of this study indicate that the absorption and subsequent bioavailability of chloramphenicol may not be 
reduced by Cd, Pb, Mn, and Zn at concentrations corresponding to WHO safe limits in drinking water. 
Bioavailability may even be enhanced especially in the intestine, which may result in therapeutic effectiveness. 
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INTRODUCTION  
Chloramphenicol, 2,2-Dichloro-N-[(α R, β R)-β-hydroxy-
α-hydroxymethyl-4-nitrophenethyl] acetamide, is a broad 
spectrum bacteriostatic antibiotic against a wide range of 
Gram-negative and Gram-positive organisms as well as 
other organisms, but at higher concentrations or against 
some very susceptible organisms it can be bactericidal 
(Sweetman, 2002). It is used in treatment of human 
infections with Salmonella typhi, and other forms of 
salmonellosis, and other life-threatening infections of 
central nervous system and respiratory tract (Parfitt, 
1999). Its ability to cause aplastic anaemia and 
resistance has limited the use of the drug. However, it is 
still widely used in low-income countries (including 
Nigeria) because of its cheapness (Sweetman, 2002). 
 
The availability of Chloramphenicol was reported to be 
significantly reduced when the drug was interacted with 
cadmium and lead in simulated gastric and intestinal pH 
at stoichiometric ratio of 2:1 (Musa et al., 2010). 
Interaction studies of ofloxacin with metal ions results in 
decrease bioavailability of ofloxacin (Sultana et al., 
2007). Availability of levofloxacin was reported to 
significantly decrease when the drug was interacted with 
several metals including Cd, Mn and Zn (Sultana et al., 
2004). Some antacids have been reported to 
significantly retard the availability of glibenclamide 
(Arayne et al., 2004). 
 
As a result of such interactions, the absorption and 
consequent bioavailability of different drugs especially 
antibiotics may be significantly affected. Heavy metals 
commonly contaminate the environment and drinking 
water sources (Musa et al., 2008). The WHO safe limits 
for Cd, Pb, Mn and Zn in drinking water are 0.003, 0.01, 
0.5 and 3 mg/L respectively (WHO, 1993). These limits 
address the toxic effects of these metals. This research 
work was aimed at evaluating the effect of Cd, Pb, Mn 
and Zn at concentrations corresponding to the WHO 
limits on the availability of chloramphenicol in simulated 
gastric and intestinal pH. 
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MATERIALS AND METHODS 
Equipment and reagents  
All metal salts (i.e. Lead chloride, Manganese Chloride, 
Zinc Chloride, Cadmium chloride and Chromium 
trioxide) and chemicals used were of analytical grade. 
Standard chloramphenicol powder was obtained as gift 
from Doyin pharmacy Nigeria limited. Chloramphenicol 
capsules were products of Green field pharmacy 
(JIANGSU) Co. Ltd (Batch-04-5485). Potassium 
dihydrogen orthophosphate was BDH-Laboratory 
reagents. Dissolution studies were performed using an 
ERWEKA (GMBH) dissolution apparatus. A double 
scanning UV/VIS spectrophotometer (Helios Zeta, Model 
164617) was used to monitor the drug content. 
 
Identification and assasy of Chloramphenicol 
Both the Chloramphenicol reference standard and 
Chloramphenicol capsules were identified and assayed 
using official methods (BP, 2002). 
 
Preparation of dissolution media 
Dissolution was carried out in simulated gastric juice 
(containing 0.1M hydrochloric acid) and intestinal pH 
(phosphate buffer pH 9). Both media were prepared 
using official methods (BP 2002). 
 
Preparation of calibration curve 
Stock solutions (1 mg/ml) of Chloramphenicol reference 
standard were prepared in 0.1M hydrochloric acid and 
phosphate buffer pH 9. The absorbance of a 50µg/ml 
solution was measured in the range of 200 – 350 nm, 
which showed maxima at 278nm. Successive serial 
dilutions of the stock were done to obtain standard 
solutions of concentrations 10, 20, 30, 40 and 50µg/ml. 
The absorbance of each solution was measured at the 
maxima (278nm). A plot of concentration against the 
corresponding absorbance was done in the case of each 
media. A straight line was obtained which obeyed the 
Beer-Lambert’s law in each case. The Chloramphenicol 
contents in the two media during the in vitro availability 
studies were extrapolated from the calibration curves. 
 
Availability of Chloramphenicol 
The in vitro availability of Chloramphenicol in simulated 
gastric juice and intestinal pH at 37◦C was determined 
using dissolution apparatus as outlined in BP (2002) with 
slight modification to the top of the basket in order to 
prevent air entrapment during dissolution. A capsule of 
chloramphenicol (250 mg) was placed in the dissolution 
basket and allowed into the dissolution medium. The 
dissolution process was monitored over a period of 180 
minutes, with aliquots (10 ml) being withdrawn at 15 
minutes intervals and assayed for drug content 
available. The volume of the dissolution medium was 
maintained after each withdrawal by an immediate 
replacement with 10 ml of the dissolution medium 
maintained at the same temperature in the same bath. 
 
For the in vitro availability of chloramphenicol in the 
presence of the metals, the drug was interacted with 
amounts equivalent to 0.01, 0.003, 0.5 and 3.0 mg/L of 
lead, cadmium, manganese and zinc salts respectively 
in each dissolution media (1L) at concentrations 
corresponding to WHO safe limits for each of the metals 
in drinking water.. The process described above was 




The results of the identification test for both 
chloramphenicol reference standard and capsules 
revealed the presence of the active ingredient and the 
content assayed was within the official limits (98-105%). 
For the qualitative determination of drug content, it was 
observed that the calibration curves of chloramphenicol 
in both simulated gastric juice (0.1M hydrochloric acid) 
and intestinal pH (Phosphate buffer pH9) at 278nm 
obeyed the Beer-Lambert’s Law. The linear relationship 
between absorbance (A) and concentration (C in % w/v) 
is given by the regression equation A=0.030C + 0.003 
and A=0.033C + 0.002 for chloramphenicol in 0.1M 
hydrochloric acid and phosphate buffer pH9 
respectively. The coefficient of correlation (r) in each 
case is 0.999. The calculated molar absorbtivities were 
1,061 ± 0.0004 M-1cm-1 and 1,123 ± 0.0003 M-1cm-1 for 
0.1M hydrochloric acid and phosphate buffer pH9 
respectively. 
 
The results of the in vitro availability of chloramphenicol 
at different time intervals in simulated gastric juice and 
intestinal pH at 37ᴼC alone and in the presence of Cd, 
Mn, Pb, and Zn in their concentration corresponding to 





Nigerian Journal of Basic and Applied Science (March-June, 2014), 22(1&2): 47-50 
49 





Cpc +  Cd 
(% Conc.) 
Cpc + Mn 
(% Conc.) 
Cpc + Pb 
 (% Conc.) 























































































Cpc +  Cd 
(% Conc.) 
Cpc + Mn 
(% Conc.) 
Cpc + Pb 
(% Conc.) 













































































In simulated gastric juice at 37◦C chloramphenicol 
achieved a maximum availability of 99.48% (248.70mg/l) 
alone and respective maximum availabilities of 89.48%, 
93.60%, 105.88% and 93.60% (223.70, 234.00, 264.70 
and 234.00 mg/l) in the presence of Cd, Mn, Pb and Zn. 
Presence of Cd,  Mn and Zn did not affect the availability 
of chloramphenicol, while the availability of the drug was 
increased in the presence of  Pb. The increase in 
concentration of the drug in this study is contrary to what 
was reported by Musa et al. (2010), also in the in vitro 
availability and interaction studies of ciprofloxacin, 
Levofloxacin and ofloxacin in the presence of some 
metals including Cd, Mn, Pb and Zn. The little reduction 
in drug content in the presence of Cd, Mn and Zn in 
simulated gastric juice may be because the 
complexation of certain drugs by polyvalent cations is 
not favoured in acid medium (Sanchez et al., 1994) and 
also the low concentrations of the metal cations used in 
this study. 
 
In simulated intestinal pH, chloramphenicol alone 
achieved a maximum availability of 64.12 % 
(160.30mg/l) at 30◦C. The maximum availabilities of 
64.36%, 83.76%, 80.72% and 64.96% (160.90, 209.40, 
201.80 and 162.40 mg/l) were obtained in the presence 
of Cd, Mn, Pb and Zn respectively. Presence of Cd did 
not affect the maximum availability of chloramphenicol. 
However, the presence of Mn, Pb and Zn increased the 
overall maximum availability of chloramphenicol. 
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It is evident from the results that Cd did not affect the 
overall observed maximum availability of 
chloramphenicol in both media whereas presence of Pb 
increased the availability of the drug in both media. In 
simulated gastric juice, Mn and Zn did not affect the 
availability of the drug however their presence increased 
the availability of the drug in simulated intestinal pH. The 
fact that there are reports suggesting dissolution rate of 
certain antibiotics is markedly reduced at high pH values 
(Sultana et al., 1984)., a similar trend was also reported 
where the availability of levofloxacin was markedly 
reduced in the presence of different metals (including 
Cd, Mn and Zn) in a medium of pH 9 at 37◦C (Sultana et 
al., 2004), in the present study a different pattern 
emerged as increase in the availability of 
Chloramphenicol was observed in the presence of Cd, 
Pb, Mn and Zn in both media which was more 
pronounced in intestinal pH. This may be attributed to 
the fact that WHO safe limits of the metals was used in 
this study while other studies that reported significant 
decrease in availability of drug used relatively higher 
concentrations of metals (Sultana et al., 2004; Sultana et 
al., 2007; Musa et al., 2010). 
 
CONCLUSION AND RECOMMENDATIONS 
From the results obtained, it can be concluded that the 
absorption and subsequent bioavailability of 
chloramphenicol may not be reduced by Cd, Mn, Pb and 
Zn   metals at concentrations corresponding to WHO 
safe limits for each of the metals in drinking water. 
Bioavailability of drug may even be enhanced and this 
effect was observed to be more pronounced in the 
simulated intestinal pH than in simulated gastric juice 
which may result in therapeutic effectiveness. 
Furthermore, the pH of a medium is an important factor 
in the dissolution and subsequent availability of drugs as 
observed in this study. Drinking water should be treated 
to ensure the concentrations of these heavy metals are 
within the WHO safe limits as these limits have been 
shown to be adequate with respect to interaction with 
chloramphenicol. Further studies on the effect of actual 
concentrations of these metals found as contaminant in 
drug and food should be evaluated. 
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